ALTO NEUROSCIENCE INC (ANRO) Stock Income Statement
USA - New York Stock Exchange - NYSE:ANRO - US02157Q1094 - Common Stock
13.39 USD
+0.59 (+4.61%)
13.39 USD
0 (0%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 210.00K | |||
| Operating Expenses | 66.31M | 68.61M | 37.81M | 29.19M | 12.27M | |||
| Research and Development | 44.42M | 47.00M | 30.29M | 23.69M | 8.37M | |||
| Selling, General, and Administrative Expenses | 21.88M | 21.61M | 7.52M | 5.50M | 3.90M | |||
| Operating Income | -66.31M | -68.61M | -37.81M | -29.19M | -12.06M | |||
| Interest Income/Expense | 4.95M | 7.48M | 979.00K | 114.00K | 2.00K | |||
| Other Income/Expense | -220.00K | -297.00K | 525.00K | 1.37M | 2.87M | |||
| Income Before Taxes | -62.26M | -61.43M | -36.30M | -27.71M | -9.19M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -62.26M | -61.43M | -36.30M | -27.71M | -9.19M | |||
| EBITDA | -65.63M | -68.11M | -37.44M | -28.85M | -11.91M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.31 | -2.50 | -1.42 | -1.08 | -0.36 | |||
| Non GAAP EPS | -2.29 | -2.54 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -4374.76% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -5740.95% | |||
All data in USD